Stoke Therapeutics, Inc. (STOK) Operating Lease, Liability USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Stoke Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2020 to 2024.
  • Stoke Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $6.34 M, a 40.9% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $6.34 M +$1.84 M +40.9% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $6.84 M +$1.76 M +34.7% Dec 31, 2023 10-K 2024-03-25
Q3 2023 $3.32 M -$2.31 M -41.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.91 M -$2.08 M -34.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $4.5 M -$2.09 M -31.7% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $5.08 M -$1.9 M -27.2% Dec 31, 2022 10-K 2023-03-06
Q3 2022 $5.63 M +$291 K +5.45% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.99 M +$4.72 M +370% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $6.58 M +$5.72 M +658% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $6.98 M +$5.83 M +509% Dec 31, 2021 10-K 2022-03-10
Q3 2021 $5.34 M +$3.93 M +277% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.28 M -$401 K -23.9% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $868 K -$1.07 M -55.1% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.15 M Dec 31, 2020 10-Q 2021-05-10
Q3 2020 $1.42 M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.68 M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.93 M Mar 31, 2020 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.